Competitive Landscape Analysis of the Middle EAST Alpha Mannosidosis Market
The Middle EAST Alpha Mannosidosis Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by increasing awareness and diagnosis of rare genetic disorders, coupled with advancements in treatment options. The rising prevalence of Alpha Mannosidosis, a rare lysosomal storage disorder, is...
0 Σχόλια 0 Μοιράστηκε 146 Views 0 Προεπισκόπηση